Johnson & Johnson rushed to announce its famous baby powder contained no asbestos after the Food and Drug Administration triggered a recall last month—but results of J&J’s tests weren’t cut and dried.
Peter LoftusAfter the FDA triggered a recall of Johnson’s Baby Powder last month, Johnson & Johnson conducted its own tests—and the results were complicated, a review of the lab reports shows wsj.com/articles/j-j-r… via @WSJ
An advisory panel recommended Thursday that the U.S. Food and Drug Administration approve expanding the use of a fish-oil derived drug to reduce the likelihood of heart attacks and strokes in high-risk patients.
A clinical trial conducted during an epidemic in a violent swath of Congo proved that two new drugs can sharply reduce death rates from Ebola, a virus that has crossed oceans to strike victims in the U.S. and Europe.
Novartis has paused a clinical trial of its Zolgensma gene therapy after a separate study on animals raised concerns about side effects, dealing a setback to the company’s efforts to broaden the market for the world’s most expensive drug.
Congressional lawmakers who pledged to lower drug prices are confronting the prospect that intraparty divides and possible impeachment proceedings may prevent them from getting anything major done this year.
Vertex has secured a deal to supply its cystic fibrosis treatments to England’s NHS, breaking a four-year deadlock over drug prices that effectively shut the company out of one of its biggest potential markets.
Doctors are criticizing a recent recommendation from experts to give blood-thinning drugs to nearly all women who give birth by caesarean section, saying the advice may be unsafe and tainted by potential conflicts of interest.
Eli Lilly & Co. posted a lower-than-expected revenue for the latest quarter as the company provided more funding for seniors through a Medicare plan under a change in federal law that took effect this year.
Peter LoftusEli Lilly & Co. posted a lower-than-expected revenue for the latest quarter as the company provided more funding for seniors through Medicare Part D wsj.com/articles/medic… via @WSJ